Year in Review: CAR-T Therapy
Chimeric antigen receptor T cell therapy continues to be a research hotspot for immunotherapy
Related Articles
Acne, Benzoyl Peroxide, and Benzene: An Expert Weighs In
In March, Connecticut testing laboratory Valisure reported unsafe levels of benzene in a range of anti-acne skin care treatments — familiar products available from well-known…
Where Vance and Walz Stand on Major Healthcare Issues
A look at the two vice presidential nominees’ healthcare policies and records
Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients
Secondary analysis of trial data consistent with observational studies
Circulating H5N1 Bird Flu Spotted by Wastewater Monitoring During Summer
Signal has generally trailed off, but more sensitive method showed virus lingering in Texas
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6
Saxenda group six times more likely to lose at least 5% of BMI
The Promise of Radioimmunotherapy in NSCLC
In a 2022 interview at the World Conference on Lung Cancer, Gerard M. Walls, MB, MRCP, MSc, of Queen’s University Belfast in Northern Ireland, summed…
Abortion, COVID, and Obamacare Highlighted in Trump-Harris Debate
Trump says he has ‘concepts and options’ for fixing the ACA, but offers no specifics
Clinicians Star in Off-Broadway Musical About Antimicrobial Resistance
Past and present collide in a show with an important public health message
Questions Linger About Missouri Patient Who Contracted Bird Flu
Human-to-human transmission a key concern
Opinion | Your Patient Has Been Dealt a Hand With Four ACEs. What Now?
In cancer survivorship, we must address patients’ psychological wellness